source
- AI-driven biotech Fathom Therapeutics secures $47 million Series A funding and rebrands from AtommapFathom Therapeutics, the company formerly known as Atommap, announced that it has closed a $47 million Series A financing round. The capital raise will support the firm’s effort to combine artifici…
- Veradermics reports positive Phase 2/3 results for oral Rogaine in men with pattern hair lossVeradermics, a biotech that recently went public, announced that its oral formulation of Rogaine met the primary endpoints in a late-stage Phase 2/3 trial. The study enrolled men with mild-to-mode…